MacroGenics posts corporate presentation with Phase 2 interim data (TAMARACK trial)

MACROGENICS INC

Corporate presentation posted May 9, 2024; data cut-off April 12, 2024.
Presentation includes Phase 2 interim data from TAMARACK trial.
No specific numerical results disclosed in the 8-K excerpt; full presentation on company website.
Investors should review the complete presentation for material clinical updates.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.